Yvonne Maldonado, a professor of pediatric infectious diseases at Stanford University's School of Medicine, tells CNBC Make It. So focus on that benefit of the new vaccines," Dr. ![]() Uncommon (0."Don't focus too much on side effects, because I really think that the main objective here is to get people to be protected. Very common (10% or more): Fatigue (up to 64.3%), use of antipyretic/pain medication (up to 46.7%), chills (up to 31.6%) This side effect was reported in 4 participants who received the vaccine and 2 patients who received a placebo, but a causal relationship to the vaccine could not be made. Postmarketing reports: Dizziness, hypoesthesia, paresthesia īell's palsy was mild to moderate in severity, began 3 to 48 days after the last dose, included facial paralysis and facial paresis, and typically lasted 3 to 68 days. Very common (10% or more): Headache (up to 47.6%)įrequency not reported: Bell's palsy, facial paralysis Very common (10% or more): Myalgia (up to 33.7%), new/worsened muscle pain (up to 31.4%), arthralgia (up to 23.5%), new/worsened joint pain (up to 16.7%)įrequency not reported: Joint pain, muscle pain Nervous system Uncommon (0.1% to 1%): Decreased appetite Musculoskeletal Very common (10% or more): Injection site pain (up to 79.4%)Ĭommon (1% to 10%): Injection site redness, injection site swelling Metabolic Postmarketing reports: Anaphylaxis, severe allergic reactions Local Uncommon (0.1% to 1%): Lymphadenopathy Hypersensitivity Uncommon (0.1% to 1%): Nausea Hematologic Very common (10% or more): Diarrhea (up to 13.7%) Postmarketing reports: Angioedema, erythema multiforme, pruritus, skin rash, urticaria Gastrointestinal Postmarketing reports: Myocarditis, pericarditis Dermatologic The most commonly reported side effects included injection site pain, fatigue, headache, and myalgia.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |